Consumer healthcare company Geyser Brands announced its successful first test harvest and second harvest as a cannabis cultivator in accordance with Health Canada’s license to cultivate. Geyser Brands has also tripled its growing capacity for an output of 51,000 grams of CBD-dominant flower, with the aim of researching optimal cannabinoid profiles for its conditions-based healthcare products.
In addition to that, the company anticipates a 200% yield increase over the first two harvests for its third harvest, which is currently in the ground.
“Geyser Brands is a British Columbia-based company producing consumer health care products and brands through a formulation laboratory focused on enhancing the bioavailability and shelf stability of all-natural, hemp-derived cannabidiol (CBD) products. Our proprietary NanoFusion technology is at the heart of its topical, cream, beverage and baked goods, oil and tincture formulations for promoting human and pet health," the team with the company explains.
The company is working to complete a processing and sales license, which will allow it to extend its products into the regulated Canadian cannabis market and direct-to-consumer medical market.”